Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Glykos Biomedical Oy
OY
Active
Y-tunnus 2899071-2
Viikinkaari 6, 00790
Helsinki
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 8 years old
— employees
Share
Finland
/
Companies
/
Manufacture of pharmaceutical preparations
/
Glykos Biomedical Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
TK
Terja Kaarina Artimo
Audit
Audit
2022
KJ
Kaapo Juhani Saarinen
Chief Executive Officer
Chief Executive Officer
2022
TJ
Tero Juhani Satomaa
Deputy Member
Deputy Member
2018
Former (1)
JP
Jyri Pekka Heikkinen
Audit
Audit
2018 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KJ
Kaapo Juhani Saarinen
Chairperson
Chairperson
2018
RH
Ritva Hannele Niemelä
Board of Directors
Board of Directors
2018
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Glykos Biomedical Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network